These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30364881)

  • 1. BREAST CANCER HISTOPATHOLOGY IMAGE ANALYSIS PIPELINE FOR TUMOR PURITY ESTIMATION.
    Azimi V; Chang YH; Thibault G; Smith J; Tsujikawa T; Kukull B; Jensen B; Corless C; Margolin A; Gray JW
    Proc IEEE Int Symp Biomed Imaging; 2017 Apr; 2017():1137-1140. PubMed ID: 30364881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obtaining spatially resolved tumor purity maps using deep multiple instance learning in a pan-cancer study.
    Oner MU; Chen J; Revkov E; James A; Heng SY; Kaya AN; Alvarez JJS; Takano A; Cheng XM; Lim TKH; Tan DSW; Zhai W; Skanderup AJ; Sung WK; Lee HK
    Patterns (N Y); 2022 Feb; 3(2):100399. PubMed ID: 35199060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated quantification of renal interstitial fibrosis for computer-aided diagnosis: A comprehensive tissue structure segmentation method.
    Tey WK; Kuang YC; Ooi MP; Khoo JJ
    Comput Methods Programs Biomed; 2018 Mar; 155():109-120. PubMed ID: 29512490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AutoIHC-Analyzer: computer-assisted microscopy for automated membrane extraction/scoring in HER2 molecular markers.
    Tewary S; Arun I; Ahmed R; Chatterjee S; Mukhopadhyay S
    J Microsc; 2021 Jan; 281(1):87-96. PubMed ID: 32803890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An End-to-End Deep Learning Histochemical Scoring System for Breast Cancer TMA.
    Liu J; Xu B; Zheng C; Gong Y; Garibaldi J; Soria D; Green A; Ellis IO; Zou W; Qiu G
    IEEE Trans Med Imaging; 2019 Feb; 38(2):617-628. PubMed ID: 30183623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole tumor section quantitative image analysis maximizes between-pathologists' reproducibility for clinical immunohistochemistry-based biomarkers.
    Barnes M; Srinivas C; Bai I; Frederick J; Liu W; Sarkar A; Wang X; Nie Y; Portier B; Kapadia M; Sertel O; Little E; Sabata B; Ranger-Moore J
    Lab Invest; 2017 Dec; 97(12):1508-1515. PubMed ID: 28805805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD).
    Menzel M; Endris V; Schwab C; Kluck K; Neumann O; Beck S; Ball M; Schaaf C; Fröhling S; Lichtner P; Schirmacher P; Kazdal D; Stenzinger A; Budczies J
    Transl Oncol; 2023 Sep; 35():101706. PubMed ID: 37327584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Assessment of Tumor Purity and Its Clinical Implications.
    Haider S; Tyekucheva S; Prandi D; Fox NS; Ahn J; Xu AW; Pantazi A; Park PJ; Laird PW; Sander C; Wang W; Demichelis F; Loda M; Boutros PC;
    JCO Precis Oncol; 2020; 4():. PubMed ID: 33015524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-Assisted Nuclear Atypia Scoring of Breast Cancer: a Preliminary Study.
    Gandomkar Z; Brennan PC; Mello-Thoms C
    J Digit Imaging; 2019 Oct; 32(5):702-712. PubMed ID: 30719586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Image Analysis as an Adjunct to Manual Scoring of ER, PgR, and HER2 in Invasive Breast Carcinoma.
    Yousif M; Huang Y; Sciallis A; Kleer CG; Pang J; Smola B; Naik K; McClintock DS; Zhao L; Kunju LP; Balis UGJ; Pantanowitz L
    Am J Clin Pathol; 2022 Jun; 157(6):899-907. PubMed ID: 34875014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity.
    Hong TH; Cha H; Shim JH; Lee B; Chung J; Lee C; Kim NKD; Choi YL; Hwang S; Lee Y; Park S; Jung HA; Kim JY; Park YH; Sun JM; Ahn JS; Ahn MJ; Park K; Lee SH; Park WY
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33077514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep learning-based breast cancer grading and survival analysis on whole-slide histopathology images.
    Wetstein SC; de Jong VMT; Stathonikos N; Opdam M; Dackus GMHE; Pluim JPW; van Diest PJ; Veta M
    Sci Rep; 2022 Sep; 12(1):15102. PubMed ID: 36068311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automatic analysis of nuclear features reveals a non-tumoral predictor of tumor grade in bladder cancer.
    Fahoum I; Tsuriel S; Rattner D; Greenberg A; Zubkov A; Naamneh R; Greenberg O; Zemser-Werner V; Gitstein G; Hagege R; Hershkovitz D
    Diagn Pathol; 2024 Jun; 19(1):75. PubMed ID: 38851736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Composite Biomarker Image for Advanced Visualization in Histopathology.
    Shafique A; Babaie M; Gonzalez R; Batten A; Sikdar S; Tizhoosh HR
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multi-Institutional Study to Evaluate Automated Whole Slide Scoring of Immunohistochemistry for Assessment of Programmed Death-Ligand 1 (PD-L1) Expression in Non-Small Cell Lung Cancer.
    Taylor CR; Jadhav AP; Gholap A; Kamble G; Huang J; Gown A; Doshi I; Rimm DL
    Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):263-269. PubMed ID: 30640753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deriving tumor purity from cancer next generation sequencing data: applications for quantitative ERBB2 (HER2) copy number analysis and germline inference of BRCA1 and BRCA2 mutations.
    Siegmund SE; Manning DK; Davineni PK; Dong F
    Mod Pathol; 2022 Oct; 35(10):1458-1467. PubMed ID: 35902772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weakly-supervised tumor purity prediction from frozen H&E stained slides.
    Brendel M; Getseva V; Assaad MA; Sigouros M; Sigaras A; Kane T; Khosravi P; Mosquera JM; Elemento O; Hajirasouliha I
    EBioMedicine; 2022 Jun; 80():104067. PubMed ID: 35644123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurately estimating the length distributions of genomic micro-satellites by tumor purity deconvolution.
    Wang Y; Zhang X; Xiao X; Zhang FR; Yan X; Feng X; Zhao Z; Guan Y; Wang J
    BMC Bioinformatics; 2020 Mar; 21(Suppl 2):82. PubMed ID: 32164528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of continuous measures across diagnostic PD-L1 assays in non-small cell lung cancer using automated image analysis.
    Widmaier M; Wiestler T; Walker J; Barker C; Scott ML; Sekhavati F; Budco A; Schneider K; Segerer FJ; Steele K; Rebelatto MC
    Mod Pathol; 2020 Mar; 33(3):380-390. PubMed ID: 31527709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer.
    Ehteshami Bejnordi B; Veta M; Johannes van Diest P; van Ginneken B; Karssemeijer N; Litjens G; van der Laak JAWM; ; Hermsen M; Manson QF; Balkenhol M; Geessink O; Stathonikos N; van Dijk MC; Bult P; Beca F; Beck AH; Wang D; Khosla A; Gargeya R; Irshad H; Zhong A; Dou Q; Li Q; Chen H; Lin HJ; Heng PA; Haß C; Bruni E; Wong Q; Halici U; Öner MÜ; Cetin-Atalay R; Berseth M; Khvatkov V; Vylegzhanin A; Kraus O; Shaban M; Rajpoot N; Awan R; Sirinukunwattana K; Qaiser T; Tsang YW; Tellez D; Annuscheit J; Hufnagl P; Valkonen M; Kartasalo K; Latonen L; Ruusuvuori P; Liimatainen K; Albarqouni S; Mungal B; George A; Demirci S; Navab N; Watanabe S; Seno S; Takenaka Y; Matsuda H; Ahmady Phoulady H; Kovalev V; Kalinovsky A; Liauchuk V; Bueno G; Fernandez-Carrobles MM; Serrano I; Deniz O; Racoceanu D; Venâncio R
    JAMA; 2017 Dec; 318(22):2199-2210. PubMed ID: 29234806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.